Trial Profile
The Effect of Treatment With Basal Insulin Peglispro or Insulin Glargine on the Dose Response Effect of Prandial Insulin Lispro in Patients With Type 1 Diabetes Mellitus.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin peglispro (Primary) ; Insulin glargine; Insulin lispro
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Eli Lilly and Company
- 09 Dec 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 16 Nov 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 17 Jun 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.